Tenofovir alafenamide 10 mg and Emtricitabine 200 mg
Tenofovir alafenamide and Emtricitabine are HIV nucleoside analog reverse transcriptase inhibitors and are indicated as an FDC with other antiretroviral agents for the treatment of HIV-1. FDC of Tenofovir alafenamide and Emtricitabine is indicated in combination with other antiretroviral agents for treatment of HIV-1 infections in adults and adolescents with age 12 years and older.
Sustained efficacy observed with TAF after the switch from TDF, Effective therapy achieved at 90% lower systemic exposure to TFV and Improved renal and bone safety with TAF.